These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [CHANGES AFTER SMOKING, IN THE BLOOD LEVEL OF 5-HT IN ARTERIOPATHY PATIENTS]. DELLORUSSO R; CAROTENUTO A; PALADINO L Riforma Med; 1963 Dec; 77():1363-5. PubMed ID: 14127204 [No Abstract] [Full Text] [Related]
28. Thromboangiitis obliterans (Buerger's disease) in a saphenous vein arterial graft. Lie JT Hum Pathol; 1987 Apr; 18(4):402-4. PubMed ID: 3493970 [TBL] [Abstract][Full Text] [Related]
29. [Role of lysosomal enzymes in the pathogenesis of peripheral arterial diseases]. Knapik-Kordecka M Pol Arch Med Wewn; 1983 Jun; 69(6):401-6. PubMed ID: 6359085 [No Abstract] [Full Text] [Related]
30. Smoking as a risk factor for the development of arterial occlusive disease. Puchmayer V Acta Univ Carol Med Monogr; 1984; 105():1-134. PubMed ID: 6731188 [TBL] [Abstract][Full Text] [Related]
31. [A FEW IDEAS CONCERNING THE ETIOLOGY OF CHRONIC ARTERIOPATHIES OF THE EXTREMITIES]. PERRIN A J Med Lyon; 1964 Jan; 45():16-20. PubMed ID: 14125136 [No Abstract] [Full Text] [Related]
32. Pathophysiology related to peripheral vascular disease. Wagner MM Nurs Clin North Am; 1986 Jun; 21(2):195-206. PubMed ID: 3517813 [TBL] [Abstract][Full Text] [Related]
33. THERMOGRAPHY AND THE PERIPHERAL CIRCULATION. WINSOR T; BENDEZU J Ann N Y Acad Sci; 1964 Oct; 121():135-56. PubMed ID: 14237508 [No Abstract] [Full Text] [Related]
34. [Arteriosclerosis obliterans and Buerger's disease]. Ishimaru S; Yao Y Ryoikibetsu Shokogun Shirizu; 1996; (14):553-6. PubMed ID: 9047930 [No Abstract] [Full Text] [Related]
35. [Hyperproduction of immunoglobulin E in occlusive diseases of the peripheral arteries]. Baranov AA; Shilkina NP; Masenko VP; Kushekbaeva AE; Nasonov EL; Lebedin IuG Klin Med (Mosk); 1991 Apr; 69(4):45-8. PubMed ID: 1865650 [No Abstract] [Full Text] [Related]
36. Arterial disorders of the extremities: clinical syndromes; assessment and measurement. Abramson DI Arch Phys Med Rehabil; 1968 Jun; 49(6):315-25. PubMed ID: 5667243 [No Abstract] [Full Text] [Related]
37. [Thromboangiitis obliterans with involvement of coronary vessel openings]. Adler CP; Stefani FH Med Welt; 1970 Dec; 49():2095-101. PubMed ID: 5509190 [No Abstract] [Full Text] [Related]
38. [PATHOGENESIS AND ROENTGENOLOGICAL PICTURE OF CHRONIC OBLITERATING PROCESSES IN THE BLOOD VESSELS OF THE LOWER EXTREMITIES]. SKATULA L Cesk Rentgenol; 1964 May; 18():151-60. PubMed ID: 14158979 [No Abstract] [Full Text] [Related]
39. WHO's work in cardiovascular diseases: a brief review. Fejfar Z WHO Chron; 1971 Aug; 25(8):354-62. PubMed ID: 4999427 [No Abstract] [Full Text] [Related]
40. [REMOTE RESULTS OF THE TREATMENT OF PERIPHERAL VASCULAR DISEASES WITH BUTYL-NOR-SYMPATHOL (VASCULAT)]. KOWALSKA M Pol Tyg Lek; 1963 Jul; 18():1029-31. PubMed ID: 14073083 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]